FDA Approves Oral Drug Mayzent to Treat Multiple Sclerosis, Novartis
The U.S. Food and Drug Administration (FDA) has approved Mayzent tablets (siponimod) by Novartis for the treatment of Multiple Sclerosis ...
The U.S. Food and Drug Administration (FDA) has approved Mayzent tablets (siponimod) by Novartis for the treatment of Multiple Sclerosis ...
Plot No: 47, Rd Number 4A, adjacent to Bose Edifice, Golden Tulip Estate, Raghavendra Colony, Hyderabad, Telangana, India, 500084
Email: info@highereducationplus.com
© 2021 Higher Education Plus. All rights reserved.